Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules
G. Howard, T. A. Jost, T. Yankeelov, A. Brock
This study quantifies how breast cancer cell lines respond to doxorubicin over time and identifies optimal treatment intervals to improve drug efficacy.
bioRxiv · May 24, 2021Cancer Biology